EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Shiga Toxin B-Subunit-Based Lectibody Boosts T Cell Cytotoxicity towards Gb3-Positive Cancer Cells

Jana Tomisch iD, Vincent Busse, Francesca Rosato, Olga N Makshakova, Pavel Salavei, Anna-Sophia Kittel, Emilie Gillon, Levin Lataster, Anne Imberty iD, Ana Valeria Meléndez, Winfried Römer iD

Cells · 20.07.2023 · 12 (14) · 1896

DOI: 10.3390/cells12141896 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, online erschienen am 20.07.2023. Verfasst von Jana Tomisch und 10 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Biology, University of Freiburg, 79104 Freiburg, Germany. Hauptthemen laut MEDLINE: Shiga Toxin, Neoplasms. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 133 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Marie Curie, Deutsche Forschungsgemeinschaft (DFG, German Research Foundation), DFG grant RTG 2022 (‘Transport across and into membranes’).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aberrant glycosylation plays a crucial role in tumour progression and invasiveness. Tumour-associated carbohydrate antigens (TACAs) represent a valuable set of targets for immunotherapeutic approaches. The poor immunogenicity of glycan structures, however, requires a more effective and well-directed way of targeting TACAs on the surface of cancer cells than antibodies. The glycosphingolipid globotriaosylceramide (Gb3) is a well-established TACA present in a multitude of cancer types. Its overexpression has been linked to metastasis, invasiveness, and multidrug resistance. In the present study, we propose to use a dimeric fragment of the Shiga toxin B-subunit (StxB) to selectively target Gb3-positive cancer cells in a StxB-scFv UCHT1 lectibody. The lectibody, comprised of a lectin and the UCHT1 antibody fragment, was produced in E. coli and purified via Ni-NTA affinity chromatography. Specificity of the lectibody towards Gb3-positive cancer cell lines and specificity towards the CD3 receptor on T cells, was assessed using flow cytometry. We evaluated the efficacy of the lectibody in redirecting T cell cytotoxicity towards Gb3-overexpressing cancer cells in luciferase-based cytotoxicity in vitro assays. The StxB-scFv UCHT1 lectibody has proven specific for Gb3 and could induce the killing of up to 80% of Gb3-overexpressing cancer cells in haemorrhagic and solid tumours. The lectibody developed in this study, therefore, highlights the potential that lectibodies and lectins in general have for usage in immunotherapeutic approaches to boost the efficacy of established cancer treatments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Shiga ToxinNeoplasmsHumansEscherichia coliT-LymphocytesGlycosphingolipids

Stichwörter der Autor:innen

Burkitt’s lymphomaShiga toxin B-subunitT cellsbispecific T cell engagercancer immunotherapycolon cancerglobotriaosylceramideglycansglycosphingolipidslectinssolid tumourstumour-associated carbohydrate antigens

Substanzen

Shiga ToxinGlycosphingolipids

Autor:innen und Institutionen

  • Faculty of Biology, University of Freiburg, 79104 Freiburg, Germany.
  • Signalling Research Centres BIOSS and CIBSS, University of Freiburg, 79104 Freiburg, Germany.
  • Kazan Institute for Biochemistry and Biophysics, FRC Kazan Scientific Center of RAS, 420111 Kazan, Russia.
  • Core Facility Signalling Factory & Robotics, University of Freiburg, 79104 Freiburg, Germany.
  • CNRS, CERMAV, Université Grenoble Alpes, 38000 Grenoble, France.
  • Spemann Graduate School of Biology and Medicine, University of Freiburg, 79104 Freiburg, Germany.

ORCID-Profile: Jana Tomisch, Anne Imberty, Winfried Römer

Förderung

  • Marie Curie
  • Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)
  • DFG grant RTG 2022 (‘Transport across and into membranes’)
  • European Union’s Horizon 2020 Research and Innovation Program
  • COST (European Cooperation in Science and Technology)
  • the government assigned for FRC Kazan Scientific Center of RAS

Zitieren

APA

Tomisch, J., Busse, V., Rosato, F., Makshakova, O. N., Salavei, P., Kittel, A. S., Gillon, E., Lataster, L., Imberty, A., Meléndez, A. V., & Römer, W. (2023). A Shiga Toxin B-Subunit-Based Lectibody Boosts T Cell Cytotoxicity towards Gb3-Positive Cancer Cells. Cells, 12(14), 1896. https://doi.org/10.3390/cells12141896

Vancouver

Tomisch J, Busse V, Rosato F, Makshakova ON, Salavei P, Kittel AS, et al. A Shiga Toxin B-Subunit-Based Lectibody Boosts T Cell Cytotoxicity towards Gb3-Positive Cancer Cells. Cells. 2023;12(14):1896. doi:10.3390/cells12141896

BibTeX
@article{Tomisch2023,
  author = {Tomisch, Jana and Busse, Vincent and Rosato, Francesca and Makshakova, Olga N and Salavei, Pavel and Kittel, Anna-Sophia and Gillon, Emilie and Lataster, Levin and Imberty, Anne and Meléndez, Ana Valeria and Römer, Winfried},
  title = {A Shiga Toxin B-Subunit-Based Lectibody Boosts T Cell Cytotoxicity towards Gb3-Positive Cancer Cells},
  journal = {Cells},
  year = {2023},
  volume = {12},
  number = {14},
  pages = {1896},
  doi = {10.3390/cells12141896}
}
Kostenlos starten →